Est. 2001·3,000+ placements · six offices · four regions

Company signals · MedTech

Analog Devices

2 signals in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: This lands while the Talent Market Index reads 105.8 (Hot) — down 2.4 versus the prior month — and Americas signal share is rising (+2.4pts).

Analog Devices: 2 signals in the last 90 days — above the MedTech median of 1 across 20 tracked companies; 0.1% of MitchelLake's Americas signal flow; 2 tracked across 51 days.

Signals at Analog Devices

More signals across MedTech

Ma Activity · Americas

Medtronic

Medtronic completed acquisition of SPR Therapeutics for $650M cash. SPR specializes in FDA-cleared short-term peripheral nerve stimulation (PNS) therapy for chronic and acute pain. Deal adds SPRINT PNS System to Medtronic's neuromodulation portfolio.

Ma Activity · Americas

QuidelOrtho

QuidelOrtho plans to divest its testing unit for $1.5 billion

Ma Activity · Americas

Boston Scientific

Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer

Ma Activity · Americas

McKesson

McKesson planning medical-surgical spinoff and share buyback program, indicating major portfolio restructuring

Ma Activity · Americas

QuidelOrtho Corporation

QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes

Ma Activity · Americas

Abbott

Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market

Weekly briefing

Track companies like Analog Devices — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗